Industry: Chemical & Material
Published Date: 2025-02-24
Pages: 99 Pages
Report ld: 4186876
Request Sample
Customized Report
The global market for Animal-Derived Chymosin was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China"s Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China"s pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 273%.
This report aims to provide a comprehensive presentation of the global market for Animal-Derived Chymosin, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Animal-Derived Chymosin by region & country, by Type, and by Application.
The Animal-Derived Chymosin market size, estimations, and forecasts are provided in terms of sales volume (K MT) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Animal-Derived Chymosin.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Animal-Derived Chymosin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Animal-Derived Chymosin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Animal-Derived Chymosin in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Animal-Derived Chymosin Product Introduction
1.2 Global Animal-Derived Chymosin Market Size Forecast
1.2.1 Global Animal-Derived Chymosin Sales Value (2020-2031)
1.2.2 Global Animal-Derived Chymosin Sales Volume (2020-2031)
1.2.3 Global Animal-Derived Chymosin Sales Price (2020-2031)
1.3 Animal-Derived Chymosin Market Trends & Drivers
1.3.1 Animal-Derived Chymosin Industry Trends
1.3.2 Animal-Derived Chymosin Market Drivers & Opportunity
1.3.3 Animal-Derived Chymosin Market Challenges
1.3.4 Animal-Derived Chymosin Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Animal-Derived Chymosin Players Revenue Ranking (2024)
2.2 Global Animal-Derived Chymosin Revenue by Company (2020-2025)
2.3 Global Animal-Derived Chymosin Players Sales Volume Ranking (2024)
2.4 Global Animal-Derived Chymosin Sales Volume by Company Players (2020-2025)
2.5 Global Animal-Derived Chymosin Average Price by Company (2020-2025)
2.6 Key Manufacturers Animal-Derived Chymosin Manufacturing Base and Headquarters
2.7 Key Manufacturers Animal-Derived Chymosin Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Animal-Derived Chymosin
2.9 Animal-Derived Chymosin Market Competitive Analysis
2.9.1 Animal-Derived Chymosin Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Animal-Derived Chymosin Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Animal-Derived Chymosin as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Chymosin Liquid
3.1.2 Chymosin Powder
3.1.3 Chymosin Tablets
3.2 Global Animal-Derived Chymosin Sales Value by Type
3.2.1 Global Animal-Derived Chymosin Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Animal-Derived Chymosin Sales Value, by Type (2020-2031)
3.2.3 Global Animal-Derived Chymosin Sales Value, by Type (%) (2020-2031)
3.3 Global Animal-Derived Chymosin Sales Volume by Type
3.3.1 Global Animal-Derived Chymosin Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Animal-Derived Chymosin Sales Volume, by Type (2020-2031)
3.3.3 Global Animal-Derived Chymosin Sales Volume, by Type (%) (2020-2031)
3.4 Global Animal-Derived Chymosin Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Food & Beverage
4.1.2 Pharmaceutical
4.1.3 Biochemical Engineering
4.1.4 Other
4.2 Global Animal-Derived Chymosin Sales Value by Application
4.2.1 Global Animal-Derived Chymosin Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Animal-Derived Chymosin Sales Value, by Application (2020-2031)
4.2.3 Global Animal-Derived Chymosin Sales Value, by Application (%) (2020-2031)
4.3 Global Animal-Derived Chymosin Sales Volume by Application
4.3.1 Global Animal-Derived Chymosin Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Animal-Derived Chymosin Sales Volume, by Application (2020-2031)
4.3.3 Global Animal-Derived Chymosin Sales Volume, by Application (%) (2020-2031)
4.4 Global Animal-Derived Chymosin Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Animal-Derived Chymosin Sales Value by Region
5.1.1 Global Animal-Derived Chymosin Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Animal-Derived Chymosin Sales Value by Region (2020-2025)
5.1.3 Global Animal-Derived Chymosin Sales Value by Region (2026-2031)
5.1.4 Global Animal-Derived Chymosin Sales Value by Region (%), (2020-2031)
5.2 Global Animal-Derived Chymosin Sales Volume by Region
5.2.1 Global Animal-Derived Chymosin Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Animal-Derived Chymosin Sales Volume by Region (2020-2025)
5.2.3 Global Animal-Derived Chymosin Sales Volume by Region (2026-2031)
5.2.4 Global Animal-Derived Chymosin Sales Volume by Region (%), (2020-2031)
5.3 Global Animal-Derived Chymosin Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Animal-Derived Chymosin Sales Value, 2020-2031
5.4.2 North America Animal-Derived Chymosin Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Animal-Derived Chymosin Sales Value, 2020-2031
5.5.2 Europe Animal-Derived Chymosin Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Animal-Derived Chymosin Sales Value, 2020-2031
5.6.2 Asia Pacific Animal-Derived Chymosin Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Animal-Derived Chymosin Sales Value, 2020-2031
5.7.2 South America Animal-Derived Chymosin Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Animal-Derived Chymosin Sales Value, 2020-2031
5.8.2 Middle East & Africa Animal-Derived Chymosin Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Animal-Derived Chymosin Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Animal-Derived Chymosin Sales Value
6.2.1 Key Countries/Regions Animal-Derived Chymosin Sales Value, 2020-2031
6.2.2 Key Countries/Regions Animal-Derived Chymosin Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Animal-Derived Chymosin Sales Value, 2020-2031
6.3.2 United States Animal-Derived Chymosin Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Animal-Derived Chymosin Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Animal-Derived Chymosin Sales Value, 2020-2031
6.4.2 Europe Animal-Derived Chymosin Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Animal-Derived Chymosin Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Animal-Derived Chymosin Sales Value, 2020-2031
6.5.2 China Animal-Derived Chymosin Sales Value by Type (%), 2024 VS 2031
6.5.3 China Animal-Derived Chymosin Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Animal-Derived Chymosin Sales Value, 2020-2031
6.6.2 Japan Animal-Derived Chymosin Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Animal-Derived Chymosin Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Animal-Derived Chymosin Sales Value, 2020-2031
6.7.2 South Korea Animal-Derived Chymosin Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Animal-Derived Chymosin Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Animal-Derived Chymosin Sales Value, 2020-2031
6.8.2 Southeast Asia Animal-Derived Chymosin Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Animal-Derived Chymosin Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Animal-Derived Chymosin Sales Value, 2020-2031
6.9.2 India Animal-Derived Chymosin Sales Value by Type (%), 2024 VS 2031
6.9.3 India Animal-Derived Chymosin Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Chr. Hansen Holding
7.1.1 Chr. Hansen Holding Company Information
7.1.2 Chr. Hansen Holding Introduction and Business Overview
7.1.3 Chr. Hansen Holding Animal-Derived Chymosin Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Chr. Hansen Holding Animal-Derived Chymosin Product Offerings
7.1.5 Chr. Hansen Holding Recent Development
7.2 Clarion Casein
7.2.1 Clarion Casein Company Information
7.2.2 Clarion Casein Introduction and Business Overview
7.2.3 Clarion Casein Animal-Derived Chymosin Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Clarion Casein Animal-Derived Chymosin Product Offerings
7.2.5 Clarion Casein Recent Development
7.3 Clover Fonterra Ingredients
7.3.1 Clover Fonterra Ingredients Company Information
7.3.2 Clover Fonterra Ingredients Introduction and Business Overview
7.3.3 Clover Fonterra Ingredients Animal-Derived Chymosin Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Clover Fonterra Ingredients Animal-Derived Chymosin Product Offerings
7.3.5 Clover Fonterra Ingredients Recent Development
7.4 DowDuPont
7.4.1 DowDuPont Company Information
7.4.2 DowDuPont Introduction and Business Overview
7.4.3 DowDuPont Animal-Derived Chymosin Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 DowDuPont Animal-Derived Chymosin Product Offerings
7.4.5 DowDuPont Recent Development
7.5 Osterreichische Laberzeugung Hundsbichler
7.5.1 Osterreichische Laberzeugung Hundsbichler Company Information
7.5.2 Osterreichische Laberzeugung Hundsbichler Introduction and Business Overview
7.5.3 Osterreichische Laberzeugung Hundsbichler Animal-Derived Chymosin Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Osterreichische Laberzeugung Hundsbichler Animal-Derived Chymosin Product Offerings
7.5.5 Osterreichische Laberzeugung Hundsbichler Recent Development
7.6 Renco
7.6.1 Renco Company Information
7.6.2 Renco Introduction and Business Overview
7.6.3 Renco Animal-Derived Chymosin Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Renco Animal-Derived Chymosin Product Offerings
7.6.5 Renco Recent Development
8 Industry Chain Analysis
8.1 Animal-Derived Chymosin Industrial Chain
8.2 Animal-Derived Chymosin Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Animal-Derived Chymosin Sales Model
8.5.2 Sales Channel
8.5.3 Animal-Derived Chymosin Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Animal-Derived Chymosin was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-15
Pages: 131
USD 3950.00
(Single User License)
The global Animal-Derived Chymosin market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-28
Pages: 132
USD 2900.00
(Single User License)
The global Animal-Derived Chymosin market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-26
Pages: 143
USD 4900.00
(Single User License)
The global Animal-Derived Chymosin market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 79
USD 4250.00
(Single User License)
The global market for Animal-Derived Chymosin was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-24
Pages: 86
USD 2900.00
(Single User License)
The global Animal-Derived Chymosin market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published Date: 2024-04-22
Pages: 93
USD 4900.00
(Single User License)
The global Animal-Derived Chymosin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-31
Pages: 87
USD 2900.00
(Single User License)
The global market for Animal-Derived Chymosin was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-15
Pages: 131
The global Animal-Derived Chymosin market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-28
Pages: 132
The global Animal-Derived Chymosin market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-26
Pages: 143
The global Animal-Derived Chymosin market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 79
The global market for Animal-Derived Chymosin was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-24
Pages: 86
The global Animal-Derived Chymosin market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published: 2024-04-22
Pages: 93
The global Animal-Derived Chymosin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-31
Pages: 87
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now